Patents by Inventor Jacqueline Walling

Jacqueline Walling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY USING PENTAFLUOROBENZENESULFONAMIDES AND ANTINEOPLASTIC AGENTS
    Publication number: 20070248692
    Abstract: Combination therapies are provided for the treatment of proliferative disorders which use a pentafluorobenzenesulfonamide of formula I and an antineoplastic agent.
    Type: Application
    Filed: March 16, 2007
    Publication date: October 25, 2007
    Applicants: AMGEN INC., HEALTH RESEARCH, INC.
    Inventors: Fengzhi Li, Xiang Ling, Youcef Rustum, Susan Schwendner, Pieter Timmermans, Jacqueline Walling
  • Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
    Publication number: 20050250854
    Abstract: Combination therapies are provided for the treatment of proliferative disorders which use a pentafluorobenzenesulfonamide of formula I and an antineoplastic agent.
    Type: Application
    Filed: November 23, 2004
    Publication date: November 10, 2005
    Applicants: Amgen Inc., Health Research, Inc.
    Inventors: Fengzhi Li, Xiang Ling, Youcef Rustum, Susan Schwendner, Pieter Timmermans, Jacqueline Walling
  • Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
    Patent number: 6822001
    Abstract: Combination therapies are provided for the treatment of proliferative disorders which use a pentafluorobenzenesulfonamide of formula I and an antineoplastic agent such as gemcitabine or paclitaxel.
    Type: Grant
    Filed: November 2, 2001
    Date of Patent: November 23, 2004
    Assignee: Tularik Inc.
    Inventors: Susan Schwendner, Pieter Timmermans, Jacqueline Walling
  • Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
    Publication number: 20020177548
    Abstract: Combination therapies are provided for the treatment of proliferative disorders which use a pentafluorobenzenesulfonamide of formula I and an antineoplastic agent such as gemcitabine or paclitaxel.
    Type: Application
    Filed: November 2, 2001
    Publication date: November 28, 2002
    Applicant: Tularik Inc.
    Inventors: Susan Schwendner, Pieter Timmermans, Jacqueline Walling
  • Combination therapy using pentafluorobenzenesulfonamides
    Patent number: 6355628
    Abstract: Combination therapies are provided for the treatment of proliferative disorders which use a pentafluorobenzenesulfonamide of formula I and an antineoplastic platinum coordination complex such as cisplatin.
    Type: Grant
    Filed: July 27, 2000
    Date of Patent: March 12, 2002
    Assignee: Tularik Inc.
    Inventors: Susan Schwendner, Pieter Timmermans, Jacqueline Walling